Rhone Ma Holdings BhdXKLS:5278 61 Gross Margin % is 31.77% as of Mar. 2026, which is 12% above its 10-year median of 28.46. GuruFocus rates XKLS:5278 with a GF Score™ of 61/100 and a GF Value™ of RM0.80 (Modestly Undervalued). Among 938 Drug Manufacturers companies, Rhone Ma Holdings Bhd ranks worse than 78.04% on this metric.
XKLS:5278's Gross Margin % is ranked worse than 78.04% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs XKLS:5278: 31.80
Rhone Ma Holdings Bhd had a gross margin of 31.77% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Rhone Ma Holdings Bhd was 1.00% per year.
Rhone Ma Holdings Bhd (XKLS:5278) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Rhone Ma Holdings Bhd had a gross margin of 31.77% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Rhone Ma Holdings Bhd Gross Margin % Related Terms
Rhone Ma Holdings Bhd Gross Margin % Historical Data
* Premium members only.
The historical data trend for Rhone Ma Holdings Bhd's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:5278 vs ZTS, UTHR, VTRS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Rhone Ma Holdings Bhd's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhone Ma Holdings Bhd Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rhone Ma Holdings Bhd's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Rhone Ma Holdings Bhd's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Rhone Ma Holdings Bhd (XKLS:5278) has a Gross Margin % of 31.77% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Rhone Ma Holdings Bhd and its competitors. This is 12% above median its historical median of 28.46. Over the past decade, Rhone Ma Holdings Bhd's Gross Margin % has ranged from 26.68 to 31.80. According to the industry distribution chart, Rhone Ma Holdings Bhd ranks #732 out of 938 companies in the Drug Manufacturers industry, placing it in the top 78%.
Is Rhone Ma Holdings Bhd's Gross Margin % too high?
Rhone Ma Holdings Bhd's current Gross Margin % of 31.77% is 12% above median its 10-year median of 28.46. Over the past 10 years, this metric has ranged from a low of 26.68 to a high of 31.80. The Drug Manufacturers industry median Gross Margin % is 48.54. Rhone Ma Holdings Bhd's value of 31.77% is 34.5% below this industry median. Based on the distribution chart, Rhone Ma Holdings Bhd ranks #732 out of 938 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Rhone Ma Holdings Bhd has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rhone Ma Holdings Bhd's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Rhone Ma Holdings Bhd ranks #732 out of 938 companies for Gross Margin %. This places Rhone Ma Holdings Bhd in the lower half of its industry. The industry median Gross Margin % is 48.54. Rhone Ma Holdings Bhd's value of 31.77% is 34.5% below this benchmark. Historically, Rhone Ma Holdings Bhd's own Gross Margin % has ranged from 26.68 to 31.80 over the past decade. While the company's 10-year median is 28.46 vs. the industry median of 48.54, Rhone Ma Holdings Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhone Ma Holdings Bhd's current Gross Margin % of 31.77% is 34.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Rhone Ma Holdings Bhd and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhone Ma Holdings Bhd's current Gross Margin % is 31.77%, which is 12% above median its own 10-year median of 28.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhone Ma Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Rhone Ma Holdings Bhd (XKLS:5278) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.80, compared to a current price of RM0.69 — trading 13.8% below its estimated fair value. The current Gross Margin % is 31.77%, which is 12% above median its 10-year median of 28.46 and 34.5% below the Drug Manufacturers industry median of 48.54. Rhone Ma Holdings Bhd's overall GF Score™ is 61/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Rhone Ma Holdings Bhd (XKLS:5278), the current Gross Margin % is 31.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rhone Ma Holdings Bhd (XKLS:5278) Overvalued in 2026?
Based on GuruFocus' analysis, Rhone Ma Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.69 is trading 13.8% below its estimated GF Value™ of RM0.80.
GuruFocus considers Rhone Ma Holdings Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:5278:
Gross Margin %: 31.77% (12% above median its 10-year median of 28.46)
GF Value™: RM0.80 vs. price of RM0.69 (13.8% below fair value)
Industry Position: 34.5% below the Drug Manufacturers median (#732 of 938)
No single metric tells the full story. See the XKLS:5278 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rhone Ma Holdings Bhd, along with its subsidiaries, is mainly involved in the provision of end-to-end animal health solutions. The Group provides veterinary consultation services, diagnostic laboratory analyses, R&D, and is engaged in the manufacturing and distribution of animal health products. Its reportable segments are: Animal health products and equipment, Food ingredients, and Others. The majority of its revenue is generated from the Animal health products and equipment segment, which is engaged in marketing, trading, distribution, and manufacturing of animal health products and equipment, such as pharmaceuticals, vaccines, feed additives, pesticides, and others. Geographically, the Group's operations are predominantly located in Malaysia.
61GF Score
Get the complete analysis for XKLS:5278
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5278 has been successfully added to your 
